Target price within three years...I think that if they get phase two going, we will hit 2.00 within the year and with good results reported quarterly, we will see 6.00 a year later. As well hopefully continue 95% efficacy and push toward the end of the phase, the stock will rocket to between 30-50.00. That’s how I see it but I find it incredibly hard to price a cancer cure...it should be far more than 50.00, more like 100-150 per share for saving lives.
keep in mind that once revenue starts with our blatter cure, we have several other indications that are following behind and will add to our portfolio of cures which will drive our earnings through the roof and with it our share price.
All this to say say things will look up if phase 2 gets going. One other consideration? Big Pharma buying tlt for 15-20 billion at least.
come on tlt and get phase 2 going and start saving lives.